Hostname: page-component-586b7cd67f-gb8f7 Total loading time: 0 Render date: 2024-11-24T20:32:29.739Z Has data issue: false hasContentIssue false
  • English
  • Français

Screening for Congenital Abnormalities

Published online by Cambridge University Press:  10 March 2009

Neil A. Holtzman
Neil A. Holtzman
Affiliation:
The Johns Hopkins University
Get access Rights & Permissions [Opens in a new window]

Extract

Improvements in nutrition, sanitation, housing, and medical care have been associated with reductions in infectious diseases of infancy, such as diarrhea, and, concomitantly, with a decline in infant mortality. Although deaths from congenital abnormalities have also decreased, the rate of their decline has not kept pace with the overall rate. Thus in the United States they have become the most frequent cause of infant death (58). For abnormalities detected in the newborn period, which comprise 3% of all births, about 8 per cent are due to single gene disorders, 6 to 12% to chromosome abnormalities, and less than 5% to viral infections of the mother (39,69). Little is known about underlying causes in the remainder; polygenic factors, environmental agents, and, probably the most common, genetic-environmental interactions, account for them. Congenital abnormalities also contribute substantially to childhood hospitalizations in several developed countries (17). One chromosome disorder, Down's syndrome, accounts for about 16 to 30% of all severe mental retardation, with other genetic and chromosome disorders contributing another 15 to 20% (58). Although the incidence of congenital abnormalities differs to some extent geographically (39), it seems likely that as any country develops, the proportion of infant mortality and childhood disability due to congenital abnormalities will increase.

Type
The Technology of Prenatal Care
Information
International Journal of Technology Assessment in Health Care , Volume 1 , Issue 4 , October 1985 , pp. 805 - 819
Copyright
Copyright © Cambridge University Press 1985

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

REFERENCES

1.Adams, M. J., Windham, G. C, James, L. M., Greenberg, F., Clayton-Hopkins, J. A., Reimer, C. B., & Oakley, G. P.Clinical interpretation of maternal serum alpha-fetoprotein concentrations. American Journal of Obstetrics and Gynecology, 1984, 148, 241–54.CrossRefGoogle ScholarPubMed
2.Angastiniotis, M. A. & Hadjiminas, M. G.Prevention of thalassaemia in Cyprus. Lancet, 1981, 1, 369–70.CrossRefGoogle ScholarPubMed
3. Anon.Diagnostic ultrasound in pregnancy. Lancet, 1984, ii, 201–2.Google Scholar
4.Bakketeig, L. S., Jacobsen, G., Brodtkorb, C. J., Erikson, B. C., Eik-Nes, S. H., Ulstein, M. K., Balstad, P., & Jorgensen, N. P.Randomised controlled trial of ultra-sonographic screening in pregnancy. Lancet, 1984, ii, 207–10.CrossRefGoogle Scholar
5.Bennett, M. J., Gau, G. S., & Gau, D. W.Women's attitudes to screening for neural tube defects. British Journal of Obstetrics and Gynecology, 1980, 87, 370–1.CrossRefGoogle ScholarPubMed
6.Bernhardt, B. A. & Bannerman, R. M.The influence of obstetricians on the utilization of amniocentesis. Prenatal Diagnosis, 1980, 2, 115–21.CrossRefGoogle Scholar
7.Beyer, E. M. & Wiederschain, G.Activity and multiple forms of alpha-L-fucosidase and hexosaminidase in chorion biopsy specimens and some fetal organs. Prenatal Diagnosis, 1984, 4, 43–9.CrossRefGoogle ScholarPubMed
8.Boehm, C. D., Antonarakis, S. E., Phillips, J. A., Stetten, G., & Kazazian, H. H. Jr, Prenatal diagnosis using DNA polymorphisms: report on 95 pregnancies at risk for sickle-cell disease or α-thalassemia. New England Journal of Medicine, 1983, 308, 1054–58.CrossRefGoogle ScholarPubMed
9.Cao, A., Furbetta, M., Galanello, R., Melis, M. A., Angius, A., Ximenes, A., Rosatelli, C., Ruggeri, R., Addis, M., Tuveri, T., Falchi, A. M., Paglietti, E., & Scalas, M. T.Prevention of homozygous alpha-thalassemia by carrier screening and prenatal diagnosis in Sardinia. American Journal of Human Genetics, 1981, 33, 592–605.Google Scholar
10.Carstensen, E. L. & Gates, A. H.The effects of pulsed ultrasound on the fetus. Journal of Ultrasound in Medicine, 1984, 3, 145–7.CrossRefGoogle ScholarPubMed
11.Clow, C. L. & Scriver, C. R.Knowledge about and attitudes toward genetic screening among high-school students: the Tay-Sachs experience. Pediatrics, 1977, 59, 86–91.CrossRefGoogle ScholarPubMed
12.Collaborative Acetylcholinesterase Study. Amniotic fluid acetylcholinesterase electrophoresis as a secondary test in the diagnosis of anencephaly and open spina bifida in early pregnancy. Lancet, 1977, ii, 321–6.Google Scholar
13.Cowart, V.NIH considers large-scale study to evaluate chorionic villi sampling (news). Journal of the American Medical Association, 1984, 252, 11–5.CrossRefGoogle Scholar
14.Cuckle, M. S., Wald, N. J., & Lindenbaum, R. H.Maternal serum alpha-fetoprotein measurement: a screening test for Down syndrome. Lancet, 1984, i, 926–9.CrossRefGoogle Scholar
15.Daffos, F., Forestier, F., Grangeot-Keros, L., Pavlovsky, Capella M., Lebon, P., Chartier, M., & Pillot, J.Prenatal diagnosis of congenital rubella. Lancet, 1984, ii, 1–3.CrossRefGoogle Scholar
16.Eik-Nes, S., Okland, O., Aure, J. C., & Ulstein, M.Ultrasound screening in pregnancy: a randomised controlled trial. Lancet, 1984, 1, 1347.CrossRefGoogle ScholarPubMed
17.Emery, A. E. H. & Rimoin, D. L. Nature and incidence of genetic disease. In Principles and Practice of Medical Genetics, Emery, A. E. H. & Rimoin, D. L. (eds.) Edinburgh: Churchill, 1983, 1–3.Google Scholar
18.Faden, R. R., Quaid, K., Chwalow, A. J., Chase, G., Lopes, C., & Holtzman, N. A. Effects of participating in a prenatal screening program on pregnant women's attitudes toward the abortion of defective fetuses. Amer. Psychol. Assn. Meeting, presented paper, 1983.CrossRefGoogle Scholar
19.Farfel, M. R. & Holtzman, N. A.Education, consent, and counseling in sickle cell screening programs: report of a survey. American Journal of Public Health, 1984, 74, 373–5.CrossRefGoogle ScholarPubMed
20.Farrant, W.Stress after amniocentesis for high serum alpha-fetoprotein concentrations. British Medical Journal, 1980, 281, 452.CrossRefGoogle ScholarPubMed
21.Fearn, J., Hibbard, B. M., Laurence, K. M., Roberts, A., & Robinson, J. O.Screening for neuural tube defects and maternal anxiety. British Journal of Obstetrics and Gvnecology. 1982, 89, 218–21.CrossRefGoogle ScholarPubMed
22.Fletcher, J. C.Ethical and social aspects of risk predictions. Clinical Genetics. 1984, 25. 25–32.CrossRefGoogle ScholarPubMed
23.Galloway, S. M., Perry, P. E., Meneses, J., Nebert, D. W., & Pedersen, R. A.Cultured mouse embryos metabolize benzo(a)pyrene during early gestation: genetic difference detectable by sister chromatid exchange. Proceedings of the National Academy of Sciences USA. 1980. 77, 3524–28.CrossRefGoogle ScholarPubMed
24.Gleicher, N. & Elkayam, U.Cardiac problems in pregnancy. II. Fetal aspects: advances in intrauterine diagnosis and therapy. Journal of the American Medical Association. 1984. 252. 78–80.CrossRefGoogle ScholarPubMed
25.Gordis, L., Childs, B., & Roseman, M. G.Obstetricians' attitudes toward genetic screening. American Journal of Public Health. 1977, 67, 469–71.CrossRefGoogle ScholarPubMed
26.Gosden, J. R., Gosden, C. M., Christie, S., Cooke, H. J., Morsman, J. M., & Rodeck, C. H.The use of cloned Y chromosome-specific DNA probes for fetal sex determination in first trimester prenatal diagnosis. Human Genetics, 1984, 66, 347–51.CrossRefGoogle ScholarPubMed
27.Gustavii, B.Chorionic biopsy and miscarriage in first trimester. Lancet, 1984, i, 562.CrossRefGoogle Scholar
28.Hansmann, M. Prenatal diagnosis of malformations. In Fetal Ultrasonography, Borruto, F., Hansmann, M., & Wladimiroff, J. W. (eds.), New York: John Wiley and Sons, 111–22.Google Scholar
29.Harrison, M. R., Filly, R. A., Golgus, M. S., Berkowitz, R. L., Callen, P. W., Canty, T. G., Catz, C., Clewell, W. H., Depp, R., Edwards, M. S., Fletcher, J. C, Frigoletto, F. D., Garrett, W. J., Johnson, M. L., Jonsen, A., deLorimier, A. A., Liley, W. A., Mahoney, M. J., Manning, F. D., Meier, P. R., Michejda, M., Nakayama, D. K., Nelson, L., Newkirk, J. B., Pringle, K., Rodeck, C., Rosen, M. A., & Schulman, J. D.Fetal treatment 1982. New England Journal of Medicine, 1982, 307, 1651–52.CrossRefGoogle ScholarPubMed
30.Holtzman, N. A.Genetic screening: for better or for worse? Pediatrics, 1977, 59, 131–3.CrossRefGoogle ScholarPubMed
31.Holtzman, N. A. Report on genetic services to the Ministry of Health, State of Israel, 1982.Google Scholar
32.Holtzman, N. A., Leonard, C. O., & Farfel, M. R.Issues in antenatal and neonatal screening and surveillance for hereditary and congenital disorders. Annual Review of Public Health, 1981, 2, 219–51.CrossRefGoogle ScholarPubMed
33.Hughey, M. J.Routine ultrasound for detection and management of the small-for-gestational-age fetus. Obstetrics and Gynecology, 1984, 64, 101–7.Google ScholarPubMed
34.Hunter, K., Stagno, S., Capps, E., & Smith, R. J.Prenatal screening of pregnant women for infections caused by cytomegalovirus, Epstein-Barr virus, herpes virus, rubella, and toxoplasma gondii. American Journal of Obstetrics and Gynecology, 1983, 145, 269–73.CrossRefGoogle ScholarPubMed
35.Jacobsen-Kram, D.The effects of diagnostic ultrasound on sister chromatid exchange frequencies: a review of the recent literature. Journal of Clinical Ultrasound, 1984, 12, 5–10.CrossRefGoogle Scholar
36.Joffe, A.Rubella screening. Pediatric Screening Procedures. Advances in Pediatrics, 1982, 29, 463–67.Google Scholar
37.Kaback, M. M. Screening for reproductive counseling: social, ethical and medicolegal issues in the Tay-Sachs disease experience. In Human Genetics, Part B: Medical Aspects, New York: Alan R. Liss, Inc., 1982, 447–59.Google Scholar
38.Kaback, M. M., Zieger, R. S., Reynolds, L. W., & Sonneborn, M.Approaches to the control and prevention of Tay-Sachs disease. Progress in Medical Genetics, 1974, 10, 103–34.Google Scholar
39.Kalter, H. & Warkany, J.Congenital malformations: etiologic factors and their role in prevention. New England Journal of Medicine, 1983, 308, 424–32.CrossRefGoogle ScholarPubMed
40.Kanhai, H. H. H., Gravenhorst, J. B., Van't Veer, M. B., Maas, C. J., Beverstock, G. C., & Bernini, L. F.Chorionic biopsy in management of severe rhesus isoimmunisation. Lancet, 1984, ii, 157–58.CrossRefGoogle Scholar
41.Keith, L., Danis, R. P., & Berger, G. S.Clinical experience with the prevention of Rh-isoimmunization: a historical comparative analysis. American Journal of Reproductive Immunology, 1982, 5, 84–9.CrossRefGoogle Scholar
42.Kleinman, C. S., Donnerstein, R. L., DeVore, G. R., Jaffe, C. C., Lunch, D. C., Berkowitz, R. L., Talner, N. S., & Hobbins, J. C.Fetal echocardiography for evaluation of in utero congestive heart failure: a technique for study of non-immune fetal hydrops. New England Journal of Medicine, 1982, 306, 568–75.CrossRefGoogle Scholar
43.Kullendorff, C. M., Larsson, L. T., & Jorgensen, C.The advantage of antenatal diagnosis of intestinal and urinary track malformations. British Journal of Obstetrics and Gynecology, 1984, 91, 144–7.CrossRefGoogle Scholar
44.Ley, T. J., DeSimone, J., Anagnou, N. P., Keller, G. H., Humphries, R. K., Turner, P. H., Young, N. S., Heller, P., & Nienhuis, A. W.5-azacytidine selectively increases gamma-synthesis in a patient with beta + thalassemia. New England Journal of Medicine. 1982, 307. 1469–75.CrossRefGoogle Scholar
45.Lieberman, E. et al. , Premarital rubella screening in Rhode Island. Journal of the American Medical Association, 1981, 245. 1333–35.CrossRefGoogle ScholarPubMed
46.Liebeskind, D.Sister chromatid exchange and diagnostic ultrasound. Journal of Clinical Ultrasound, 1984, 12, 3–4.CrossRefGoogle ScholarPubMed
47.Lin-Fu, J. S. Cooley's Anemia: a medical review. Public Health Service, Department of Health and Human Services, Publication No. (HSA) 81–5125, 1981.Google Scholar
48.Lippman-Hand, A. & Cohen, D. I.Influence of obstetricians' attitudes on their use of prenatal diagnosis for the detection of Down's syndrome. Canadian Medical Association Journal, 1980, 122, 1381–85.Google ScholarPubMed
49.Lituania, M., Porro, E., Cardone, M. S., & Rossi, E. O. Ultrasonographic diagnosis of congenital malformations. In Fetal Ultrasonography, Borruto, F., Hansmann, M., & Wladimiroff, J. W. (eds.) New York: John Wiley and Sons, 1982, 111–22.Google Scholar
50.Loukopoulos, D., Kaltsoya-Tassiopoulou, A., & Fessas, H.Prevention of thalassemia. Schweize Medizinische Wochenschrift, 1983, 113, 1419–27.Google ScholarPubMed
51.Marion, J. P., Kassam, G. R., Fernhoff, P. M., Brantley, K. E., Carroll, L., Zacharias, J., Klein, L., Priest, J. H., & Elsas, L. J.Acceptance of amniocentesis by low-income patients in an urban hospital. American Journal of Obstetrics and Gynecology, 1980, 138, 11–5.CrossRefGoogle Scholar
52.Martin, A. O.Can ultrasound cause genetic damage? Journal of Clinical Ultrasound, 1984. 12, 11–20.CrossRefGoogle ScholarPubMed
53.Merkatz, I. R., Nitowsky, H. M., Macri, J. N., & Johnson, W. E.An association between low maternal serum alpha-fetoprotein and fetal chromosomal abnormalities. American Journal of Obstetrics and Gynecology, 1984, 148, 886–94.CrossRefGoogle ScholarPubMed
54.Miller, E., Cradock-Watson, J. E., & Pollock, T. M.Consequences of confirmed maternal rubella at successive stages of pregnancy. Lancet, 1982, ii, 781–4.CrossRefGoogle Scholar
55.Modell, B., Ward, R. H. T., & Fairweather, D.V. I. Effect of introducing antenatal diagnosis on reproductive behaviour of families at risk for thalassemia major. British Medical Journal, 1980, 280, 1347–50.CrossRefGoogle Scholar
56.Mortimer, P. P. & Tedder, R. S.Screening for anti-rubella IgM ad libitum. Journal of Hygiene, 1983, 90, 1–5.CrossRefGoogle ScholarPubMed
57.Mouzouras, M., Ioannou, P., Camba, L., Modell, B., Constantinides, P., & Gale, R.Thalassaemia as a model of recessive genetic disease in the community. Lancet, 1980, ii, 574–78.CrossRefGoogle Scholar
58.Oakley, G. P. Jr, Incidence and epidemiology of birth defects. In Genetic Issues in Pediatric and Obstetric Practice, Kaback, M. M. (ed.), Chicago: Year Book Medical Publishers, Inc., 1981, 25–43.Google Scholar
59.Old, J. M., Ward, R. H. T., Petrou, M., Karagozlu, F., Modell, B., & Weatherall, D. J.First-trimester fetal diagnosis for haemoglobinopathies: three cases. Lancet, 1982, ii, 1413–6.CrossRefGoogle Scholar
60.Orkin, S. H.Prenatal diagnosis of hemoglobin disorders by DNA analysis. Blood, 1984, 63, 249–53.CrossRefGoogle ScholarPubMed
61. President's Commission for the Study of Ethical Problems in Medicine and Biomedical and Behavioral Research. Screening and counseling for genetic conditions. Washington: Government Printing Office, 1983, 68–70.Google Scholar
62. Report by the Working Group on Screening for Neural Tube Defects. London: Her Majesty's Stationers, 1979.Google Scholar
63.Robert, C. J., Elder, G. H., Laurence, K. M., Woodhead, J. S., Hibbard, B. M., Evans, K. T., Roberts, A., Robertson, I. B., & Hoole, M.The efficacy of a serum screening service neural tube defects: The South Wales experience. Lancet, 1983, ii, 1315–18. Congenital malformations in 10,000 consecutive births in a university hospital: need for genetic counseling and prenatal diagnosis. Journal of Pediatrics, 1984, 4. 386–90.CrossRefGoogle Scholar
64.Sepe, S. J., Markes, J. S., Oakley, G. P., & Manley, A. F.Delivery of genetic services in the United States. Journal of the American Medical Association, 1982, 248, 1733–5.CrossRefGoogle Scholar
65.Shaw, M. W.To be or not to be? That is the question. American Journal of Human Genetics, 1984, 36, 1–9.Google ScholarPubMed
66.Spielberg, S.Pharmacogenetics and the fetus. New England Journal of Medicine, 1982, 307, 115–6.CrossRefGoogle ScholarPubMed
67.Stomatoyannopoulos, G. Problems of screening and counseling in the hemoglobinopathies. In Birth Defects, Motulsky, A. G. & Lenz, W. (eds.), Amsterdam: Excerpta Medica, 1974, 268–76.Google Scholar
68.U. K. Collaborative Study on Alpha-fetoprotein in Relation to Neural-tube Defects. Maternal serum-alpha-fetoprotein measurement in antenatal screening for anencephaly and spina bifida in early pregnancy. Lancet, 1977, ii, 1323–32.Google Scholar
69.Van Regemorter, N., Dodion, J., Druart, C., Hayez, F., Vamos, E., Flament-Durand, J., Perlmutter-Cremer, N., & Rodesch, F.Congenital malformations in 10,000 consecutive births in a university hospital: need for genetic counseling and prenatal diagnosis. Journal of Pediatrics, 1984, 4, 386–90.CrossRefGoogle Scholar
70.Weatherall, D. J.Prenatal diagnosis of thalassemia. British Medical Journal, 1984, 288, 1321–2.CrossRefGoogle Scholar